Startseite › Nierenkrebs (Nierenzellkarzinom) › Texas › Dallas
Klinische Studien zu Nierenkrebs (Nierenzellkarzinom) in Dallas, TX
23 Studien zu Nierenkrebs (Nierenzellkarzinom) suchen Teilnehmer an Standorten in und um Dallas (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma
Teilnehmer gesuchtPhase 1
- NEO-811 Dallas Site, Dallas
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
Teilnehmer gesuchtPhase 1
- Texas Oncology, Dallas
- University of Texas Southwestern Medical Center, Dallas
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Teilnehmer gesuchtPhase 1
- Exelixis Clinical Site #89, Dallas
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Teilnehmer gesuchtPhase 2
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
DESTINY-PANTUMOUR04
Teilnehmer gesuchtBeobachtungsstudie
- Research Site, Dallas
Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Teilnehmer gesuchtPhase 1/2
- Baylor, Scott and White Research Institute, Dallas
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
Teilnehmer gesuchtPhase 2
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Teilnehmer gesuchtPhase 1/2
- University of Texas Southwestern Medical Center - Simmons Cancer Center, Dallas
- University of Texas Southwestern Medical Center-William P. Clements Jr. University Hospital, Dallas
- University of Texas Southwestern Simmons Cancer Center - Redbird, Dallas
- und 2 weitere
Neoadjuvant Lenvatinib and Pembrolizumab for IVC Tumor Thrombus
Teilnehmer gesuchtPhase 2
- University of Texas Southwestern Medical Center, Dallas
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
Teilnehmer gesuchtBeobachtungsstudie
- UT Southwestern Medical Center, Dallas
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Mary Crowley Cancer Research, Dallas
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
Teilnehmer gesuchtPhase 3
- Parkland Memorial Hospital, Dallas
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
Teilnehmer gesuchtPhase 2
- University of Texas, Southwestern Medical Center, Dallas
PET/MR for Characterization of Renal Masses (RMs)
Teilnehmer gesuchtBeobachtungsstudie
- University of Texas Southwestern Medical Center, Dallas
KO-2806 Monotherapy and Combination Therapies in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- UT Southwestern Simmons Cancer Center, Dallas
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
Teilnehmer gesuchtPhase 1
- University of Texas Southwestern Medical Center /ID# 251974, Dallas
Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell Carcinoma
Teilnehmer gesuchtPhase 2
- UT Southwestern Medical Center, Dallas
A Study of VET3-TGI in Patients With Solid Tumors
Teilnehmer gesuchtPhase 1
- Mary Crowley Cancer Research, Dallas
An Investigation of Kidney and Urothelial Tumor Metabolism in Patients Undergoing Surgical Resection and/or Biopsy
Teilnehmer gesuchtGesunde Freiwillige willkommen
- University of Texas Southwestern Medical Center, Dallas
[18F]PT2385 PET/CT in Patients With Renal Cell Carcinoma
Teilnehmer gesuchtPhase 1
- UT Southwestern Medical Center, Dallas
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
Teilnehmer gesuchtPhase 2
- University of Texas Southwestern Medical Center, Dallas
Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)
Teilnehmer gesuchtPhase 2
- UT Southwestern Medical Center, Dallas
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
Teilnehmer gesuchtPhase 3
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
Nierenkrebs (Nierenzellkarzinom)-Studien in anderen Städten
- Houston, TX35 Studien
- New York City, NY27 Studien
- Nashville, TN23 Studien
- St. Louis, MO23 Studien
- Los Angeles, CA20 Studien
- Boston, MA16 Studien
- Baldwin Park, CA16 Studien
- Philadelphia, PA15 Studien
- Pittsburgh, PA15 Studien
- Queens, NY15 Studien
- Rochester, MN14 Studien
- Jacksonville, FL14 Studien
Weitere Studien in Dallas
- Brustkrebs55 Studien
- Nichtkleinzelliges Lungenkarzinom52 Studien
- Metastasierender Krebs42 Studien
- Herzinsuffizienz42 Studien
- Krebs (alle Arten)37 Studien
- Prostatakrebs36 Studien
- Kolorektales Karzinom33 Studien
- Adipositas30 Studien
- Eierstockkrebs28 Studien
- Lungenkrebs27 Studien
- Blasenkrebs27 Studien
- Endometriumkarzinom24 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.